NCT01001091View on ClinicalTrials.gov

AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

PHASE2CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Allergic Conjunctivitis
Interventions
DRUG

AL-38583 ophthalmic solution

DRUG

AL-38583 ophthalmic solution vehicle

Inactive ingredients used as a placebo comparator

DRUG

Dexamethasone ophthalmic suspension, 0.1%

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
collaborator

Ophthalmic Research Associates, Inc.

INDUSTRY

lead

Alcon Research

INDUSTRY